DMAC Market Cap & Key Metrics
DiaMedica Therapeutics Inc.
$8.04
+$0.38(+4.96%)
50
Overall
40
Value
75
Tech
36
Quality
Market Cap
$413.07M
Volume
303.58K
52W Range
$5.25 - $10.42
Target Price
$15.50
DMAC market cap is $413.07M. This page lists DiaMedica Therapeutics Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
DMAC Key Metrics
- Market cap
- $413.07M
- EPS estimate, current year
- $-0.84
- EPS growth, 3-year
- -10.42%
- Value score
- 40
- Quality score
- 36
- Technical score
- 75
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| EBITDA | -$32.70M | -$24.38M | -$19.31M | -$13.98M | -$13.62M |
| EPS | $-0.70 | $-0.60 | $-0.60 | $-0.52 | $-0.65 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DMAC | $8.04 | +5.0% | 303.58K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get DiaMedica Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW